Purchase Order HHSF223201510498A
- Not listed
- This is a $301,014.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract supports a precedent-based approach to decision-making and the development of a maturity model for pharmaceutical quality system assessment. This award is a sole source contract set aside for 8(a) companies. Caitta Inc. specializes in providing...
- This is a $266,000.00 Firm Fixed Price Purchase Order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB) and 8(a) program participant. The contract is for a "Precedent Based Approach to Support Decision-Making Oncology", and was awarded as an 8(a) Sole Source contract. Caitta Inc. is a federal contractor that specializes in providing scientific, technical, and...
- This federal contract award was made by the Food and Drug Administration (FDA), a civilian agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The $132,000 Firm Fixed Price Purchase Order is for business process improvement quality services to support the FDA's 21st Century initiatives. The contract has an 8(a) sole source set-aside designation. Caitta Inc. is a federal contractor that specializes in providing...
- This is a $238,950.95 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for RESEARCH SUPPORT FOR OSIS, with an ultimate completion date of September 27, 2016. Caitta Inc. has a diverse portfolio of federal contracts, including a $2 million GSA Federal Supply Schedule contract and a $999,000 multiple-award contract with the...
- This firm-fixed-price delivery order contract was awarded to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), by the Food and Drug Administration (FDA) for regulatory health project management services. The contract has a ceiling value of $372,662.98 and an ultimate completion date of July 3, 2021. Caitta Inc. is a key supplier to federal agencies like the Department of Health and Human Services (HHS), FDA, National Institutes of Health (NIH), and...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant, for PROJECT RESEARCHER SUPPORT services. The contract has a ceiling value of $336,595.10 and an ultimate completion date of September 27, 2017. Caitta Inc. is a federal contractor that specializes in providing scientific, technical, and administrative services...
- This is a $442,329.37 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for drug shortage support services for the FDA's Office of Generic Drugs. The contract has an ultimate completion date of May 31, 2020 and was awarded on May 29, 2015. Caitta Inc. is a federal contractor that specializes in providing scientific,...
- The Department of Health and Human Services Food and Drug Administration awarded a $217,346.52 firm fixed price purchase order to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The award is for contractor support services, with a performance period ending on May 3, 2023. Caitta has a history of providing scientific, technical, and administrative services to HHS and its agencies, including the FDA, NIH, and NIST, through both competitive awards and...
- This is a $343,700 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for a precedent-based approach to support decision-making beyond lung cancer, with a completion date of September 13, 2016. Caitta Inc. has established expertise in providing scientific, technical, and administrative services to federal health...
- This is a $2,485,367.54 definitive contract awarded to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant, by the Food and Drug Administration (FDA). The contract is for expert services related to SharePoint, expert witnesses, and data integrity. It is an 8(a) sole source contract with a period of performance through April 4, 2025. Caitta Inc. specializes in providing scientific, technical, and administrative services to...
This is a $190,800 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for knowledge management services. Caitta Inc. specializes in providing scientific, technical, and administrative services to federal health and research agencies, with expertise in supplying sophisticated scientific and laboratory equipment. This contract is an 8(a) sole source award, which indicates it was set aside for 8(a) small businesses. Caitta Inc. holds a significant Federal Supply Schedule contract with the General Services Administration (GSA) and other Indefinite Delivery Vehicles, demonstrating its strategic positioning and versatility in delivering a range of services to federal agencies like the FDA, National Institutes of Health (NIH), and Centers for Disease Control and Prevention (CDC).
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $190.8k | 9/2/15 |